| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 05/03/1995 | EP0651056A1 Acetyltransferase activity measuring agent |
| 05/03/1995 | EP0650596A1 Compositions and methods for regulating cellular signal transducing systems |
| 05/03/1995 | EP0650372A1 Compounds for cancer imaging and therapy |
| 05/03/1995 | EP0386199B1 Method for introducing oxygen-17 into tissues for imaging in a magnetic resonance imaging system |
| 05/02/1995 | US5412148 Amplifier molecules derived from diethylene triaminepentaacetic acid for enhancement of diagnosis and therapy |
| 05/02/1995 | US5411888 In vitro test for dermal corrosive properties |
| 05/02/1995 | US5411730 Magnetic microparticles |
| 04/30/1995 | CA2117827A1 Acetyltransferase activity measuring agent |
| 04/27/1995 | WO1995011317A1 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 04/27/1995 | WO1995011311A1 METHOD OF BINDING MATERIAL TO THE β-AMYLOID PEPTIDE |
| 04/27/1995 | WO1995011045A1 Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 04/27/1995 | WO1995011044A1 Manganese chelate contrast agents |
| 04/27/1995 | CA2174532A1 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 04/27/1995 | CA2174501A1 Method of binding material to the .beta.-amyloid peptide |
| 04/27/1995 | CA2173972A1 Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 04/26/1995 | EP0649906A1 Nucleotide sequences coding for a protein with urease activity |
| 04/26/1995 | EP0649902A1 Animal model for use in screening of prophylactic and therapeutic agents for IgE-related diseases |
| 04/26/1995 | EP0649302A1 Therapeutic and diagnostic use of modified polymeric microcapsules |
| 04/26/1995 | CN1101857A Chinese-medicinal imaging assistant to stomach for ultrasonography B and preparing process |
| 04/25/1995 | US5410036 1',6,6'-triamino- and 6,6'-diamino- sucrose derivatives |
| 04/25/1995 | US5409689 MRI image enhancement using complexes of paramagnetic cations and amine ligands containing a mixture of phosphonate and non-phosphonate pendant arms |
| 04/25/1995 | US5409688 Gaseous ultrasound contrast media |
| 04/23/1995 | CA2118457A1 Animal model for use in screening of prophylactic and therapeutic agents for ige-related diseases |
| 04/20/1995 | WO1995010539A1 Growth differentiation factor-10 |
| 04/20/1995 | WO1995010532A1 Compounds useful in anti-allergy treatment |
| 04/20/1995 | WO1995010307A1 Radiation sensitization using texaphyrins |
| 04/20/1995 | WO1995010306A1 Prophylaxis in the parenteral administration of particulate dispersions |
| 04/20/1995 | WO1995010258A1 Inhibition of urinary calculi growth |
| 04/20/1995 | WO1995010217A2 Functionalized aza-cryptand ligands for imaging applications |
| 04/20/1995 | CA2173856A1 Compounds useful in anti-allergy treatment |
| 04/20/1995 | CA2171546A1 Growth differentiation factor-10 |
| 04/19/1995 | EP0648217A1 Novel sucrose ligands, methods for their preparation, platinum complexes derived therefrom, and methods for their usage |
| 04/19/1995 | EP0648209A1 Contrast agents for mr diagnosis |
| 04/19/1995 | EP0648203A1 Novel polyiodinated compounds, preparation thereof and use thereof as radiological contrast agents |
| 04/19/1995 | EP0648130A1 Radioiodinated benzovesamicol analogs for cholinergic nerve mapping |
| 04/19/1995 | CA2117843A1 Agent for suppressing the motor activity of gastrointestinal tracts |
| 04/18/1995 | US5407962 Emulsions of highly fluorinated organic compounds for chemotherapy |
| 04/18/1995 | US5407834 Phencyclidine and phencyclidine metabolites assay, tracers, immunogens, antibodies and reagent kit |
| 04/18/1995 | US5407676 Hydrophilic form of perfluoro compounds and a method of manufacture |
| 04/18/1995 | US5407660 Nontoxic image altering chelate of paramagnetic element carried in or on liposome |
| 04/18/1995 | US5407659 Treated calcium/oxyanion-containing particles for medical diagnostic imaging |
| 04/18/1995 | US5407657 Hybrid magnetic resonance contrast agents |
| 04/18/1995 | US5406950 Inhalable contrast agent |
| 04/13/1995 | WO1995009848A2 Polyazacycloalkanes as dichelants |
| 04/13/1995 | WO1995009564A1 Compositions and methods for magnetic resonance imaging, x-ray imaging and radiopharmaceuticals |
| 04/13/1995 | WO1995009563A1 Method for increasing nuclear magnetic resonance signals in living biological tissue |
| 04/13/1995 | CA2172735A1 Polyazacycloalkanes as dichelants |
| 04/12/1995 | EP0647618A1 New non ionic iodine-containing dimers useful as x-ray contrast agents, method for the preparation thereof, and galenical compositions containing them |
| 04/12/1995 | EP0452392B1 Heterocyclic chelating agents |
| 04/12/1995 | EP0437438B1 Contrast agents for magnetic resonance imaging of the small intestine and hepatobiliary system |
| 04/12/1995 | EP0329737B1 Tri-aza macrocycles and metal complexes thereof |
| 04/11/1995 | US5405957 Wavelength-specific photosensitive compounds and expanded porphyrin-like compounds and methods of use |
| 04/11/1995 | US5405758 DNA encoding the recombinant 40 kDA Dermatophagoides farinae allergen |
| 04/11/1995 | US5405601 Functionalized tripodal ligands for imaging applications |
| 04/11/1995 | US5405600 X-ray contrast compositions containing film-forming materials |
| 04/06/1995 | WO1995009161A1 Hepatobiliary magnetic resonance contrast agents |
| 04/06/1995 | WO1995009013A1 Metal-binding targeted polypeptide constructs |
| 04/06/1995 | WO1995008949A1 Use of photodynamic therapy to treat prostatic tissue |
| 04/06/1995 | WO1995007072A3 Active principles and gas containing microparticles |
| 04/06/1995 | CA2172625A1 Metal-binding targeted polypeptide constructs |
| 04/06/1995 | CA2150452A1 Hepatobiliary magnetic resonance contrast agents |
| 04/05/1995 | EP0646808A1 Method for monitoring the nitrogen monoxide content in a medium by electron paramagnetic resonance in lithium phthalocyanine |
| 04/05/1995 | EP0646237A1 Clay enclosed transition and rare earth metal ions as contrast agents for the gastrointestinal tract |
| 04/05/1995 | EP0646020A1 Drug screening and treatment for hiv thymocyte depletion |
| 04/04/1995 | US5403928 Fluorescent marker components and fluorescent probes |
| 04/04/1995 | US5403576 Iodo-phenylated chelates for magnetic resonance imaging |
| 04/04/1995 | US5403575 Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of using them |
| 04/04/1995 | US5403572 Diagnosis/medical/ |
| 04/04/1995 | US5402783 Positioning thickness of anionic polymeric hydrogel on skin between radiation source and treatment field |
| 04/02/1995 | CA2131969A1 Process for checking the nitrogen monoxide content of a medium by electron paramagnetic resonance using lithium phtalocyanine |
| 03/30/1995 | WO1995008772A1 Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds |
| 03/30/1995 | WO1995008551A1 Phorbine derivatives and their use in the diagnosis and therapy of cancer |
| 03/30/1995 | WO1995008351A1 Composition for use as a negative contrast medium for ultrasonically imaging the gastrointestinal tract |
| 03/30/1995 | CA2172404A1 Composition for use as a negative contrast medium for ultrasonically imaging the gastrointestinal tract |
| 03/29/1995 | EP0645146A1 Contrast media |
| 03/29/1995 | EP0645048A1 Preparation of controlled size inorganic particles for use in separations, as magnetic molecular switches, and as inorganic liposomes for medical applications |
| 03/29/1995 | EP0644777A1 Microparticles, method of producing them and their use for diagnostic purposes |
| 03/29/1995 | EP0644776A1 Use of microcapsules as contrasting agents in colour doppler sonography |
| 03/29/1995 | EP0644775A1 Cocaine receptor binding ligands |
| 03/29/1995 | CN1100728A Nucleosides and oligonucleotides having 2'-ether groups |
| 03/28/1995 | US5401828 Mutant genes present in malignant tumors, detection, tumor specific antibodies for treatment |
| 03/28/1995 | US5401493 Perfluoro-1H,-1H-neopentyl containing contrast agents and method to use same |
| 03/28/1995 | US5401492 Water insoluble non-magnetic manganese particles as magnetic resonance contract enhancement agents |
| 03/28/1995 | US5401491 NMR contrast agents |
| 03/28/1995 | US5401489 Biomodulators as universal imaging agents |
| 03/23/1995 | WO1995007992A2 Cloned glutamic acid decarboxylase |
| 03/23/1995 | WO1995007920A1 Nucleotide analogs |
| 03/23/1995 | WO1995007919A1 Method for dosing therapeutic compounds |
| 03/23/1995 | WO1995007888A1 Method for the preparation of high purity substituted benz[e]indoles and the alkaline salts thereof |
| 03/23/1995 | WO1995007653A1 Second sphere complexes as relaxation agents for image enhancement in magnetic resonance imaging |
| 03/23/1995 | CA2171868A1 Method for dosing therapeutic compounds |
| 03/22/1995 | EP0643706A1 Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles |
| 03/22/1995 | EP0643696A1 Azavesamicols |
| 03/22/1995 | EP0643583A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy |
| 03/22/1995 | EP0628024A4 Synthesis of ioversol using a minimal excess of acetoxyacetylchloride. |
| 03/22/1995 | CN1100329A Aqueous injectable formulations useful for radio-diagnosis comprising iodinated aromatic compounds used as X-ray contrast media |
| 03/21/1995 | US5399583 Hydro-monobenzoporphyrins |
| 03/21/1995 | US5399485 Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis caused by Rochalimaea henselae |
| 03/21/1995 | US5399363 IV administration for insoluble medicaments |
| 03/21/1995 | US5399340 Use of amide complex compounds |